Cargando…

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Passive serotherapy can confer immediate protection against microbial infection, but methods to rapidly generate human neutralizing monoclonal antibodies are not yet available. We have developed an improved method for Epstein-Barr virus transformation of human B cells. We used this method to analyze...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traggiai, Elisabetta, Becker, Stephan, Subbarao, Kanta, Kolesnikova, Larissa, Uematsu, Yasushi, Gismondo, Maria Rita, Murphy, Brian R, Rappuoli, Rino, Lanzavecchia, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095806/ https://www.ncbi.nlm.nih.gov/pubmed/15247913 http://dx.doi.org/10.1038/nm1080

Ejemplares similares

SARS Vaccine Protective in Mice
por: Stadler, Konrad, et al.
Publicado: (2005)

Characterization of severe acute respiratory syndrome coronavirus membrane protein
por: Voß, Daniel, et al.
Publicado: (2006)

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
por: Torres, Jonathan L., et al.
Publicado: (2022)

Immortalization of Human B Cells: Analysis of B Cell Repertoire and Production of Human Monoclonal Antibodies
por: Traggiai, Elisabetta
Publicado: (2012)

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
por: Yang, Zhi-yong, et al.
Publicado: (2004)

Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
por: Rockx, Barry, et al.
Publicado: (2010)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein
por: Voß, Daniel, et al.
Publicado: (2009)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

Conformation-Dependent High-Affinity Potent Ricin-Neutralizing Monoclonal Antibodies
por: Hu, Wei-Gang, et al.
Publicado: (2013)

Inhibiting neuraminidase can make the difference
por: Rappuoli, Rino, et al.
Publicado: (2019)

Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
por: Vacca, Fabiola, et al.
Publicado: (2022)

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
por: Sutton, Troy C., et al.
Publicado: (2015)

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
por: Xiang, Rong, et al.
Publicado: (2022)

Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies
por: Dragoni, Filippo, et al.
Publicado: (2022)

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant
por: Wang, Zhaoqian, et al.
Publicado: (2022)

A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus
por: Esqueda, Adrian, et al.
Publicado: (2023)

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells
por: Funaro, Ada, et al.
Publicado: (2008)

Animal models for SARS and MERS coronaviruses
por: Gretebeck, Lisa M, et al.
Publicado: (2015)

Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
por: Khurana, Surender, et al.
Publicado: (2009)

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses
por: Vigil, Adam, et al.
Publicado: (2018)

A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7
por: Wang, Rong, et al.
Publicado: (2019)

Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
por: Fan, Pengfei, et al.
Publicado: (2020)

Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody
por: Stass, Robert, et al.
Publicado: (2023)

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
por: Mokhtary, Pardis, et al.
Publicado: (2022)

A new dawn for monoclonal antibodies against antimicrobial resistant bacteria
por: Troisi, Marco, et al.
Publicado: (2022)

ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
por: Chen, Yuning, et al.
Publicado: (2021)

Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
por: Liao, Xuejiao, et al.
Publicado: (2022)

A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity
por: Cerino, Antonella, et al.
Publicado: (2015)

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
por: Nogales, Aitor, et al.
Publicado: (2018)

Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
por: Lu, Jiansheng, et al.
Publicado: (2018)

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants
por: Chen, Zhaochun, et al.
Publicado: (2022)

Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus
por: Doyle, Michael P., et al.
Publicado: (2022)

A Three-Monoclonal Antibody Combination Potently Neutralizes BoNT/G Toxin in Mice
por: Fan, Yongfeng, et al.
Publicado: (2023)

Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
por: Piepenbrink, Michael S., et al.
Publicado: (2022)

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
por: Andreano, Emanuele, et al.
Publicado: (2021)

High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae
por: Stazzoni, Samuele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bunh426k8tmrtk4bmp1l0p7u9e